Best Compound for CNS & Neuropeptide Research

Semax is a synthetic heptapeptide based on the ACTH(4-10) fragment, modified with a C-terminal Pro-Gly-Pro extension that confers DPP-IV resistance and nasal mucosal penetration. Its mechanism of action operates at two levels: direct activity at melanocortin receptors (MC1R, MC4R) and indirect upregulation of neurotrophic factors including BDNF, NGF, and VEGF in hippocampal and cortical neurons. The combination of melanocortin receptor pharmacology and neurotrophic factor upregulation makes Semax the most versatile tool in CNS neuropeptide research, with documented activity in ischemia, neurodegeneration, and synaptic plasticity models.

Selank is a synthetic analogue of the endogenous immunopeptide tuftsin, modified with the same Pro-Gly-Pro stabilization used in Semax. Its mechanism differs fundamentally from Semax — rather than melanocortin receptor activation, Selank modulates the GABAergic system by influencing enkephalin metabolism and GABA-A receptor expression. This makes Selank the primary research tool for studying the GABAergic modulation of anxiety-related pathways, immune-CNS interactions, and enkephalinase inhibition. It does not substantially upregulate BDNF, distinguishing its mechanism clearly from Semax.

DSIP (delta sleep-inducing peptide) is an endogenous nonapeptide originally isolated from cerebral venous blood of sleeping rabbits. Its neuroendocrine mechanism involves hypothalamic modulation — influencing LH, GH, and corticotropin release patterns through direct hypothalamic peptide receptor interactions. Used in neuroendocrine signaling research, hypothalamic peptide receptor studies, and research into the intersection of sleep architecture with neuroendocrine function at the cellular level.